Episode 27: Preventing The Antimicrobial Resistance Health Crisis
- Courriel
-
Signet
-
Imprimer
Disponible en anglais seulement
November 18 marked the start of World Antimicrobial Awareness Week 2020, which aims to bring attention to the ever-evolving public health crisis of antimicrobial resistance (AMR) due to the overuse and misuse of antibiotics around the world.
Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, and James Anderson, Head of Corporate Government Affairs at GlaxoSmithKline, who leads the company’s advocacy on AMR, joins the podcast to discuss how antibiotic use in humans, livestock and plants is fueling AMR today. Plus, they provide an overview of engagement in this space to encourage responsible antibiotic use globally.
In this episode:
-
What is antimicrobial resistance and why is it such a pressing issue?
-
How the AMR Industry Alliance is combatting antibiotic overuse
-
Consumers and investors hold power to change antibiotic usage
-
The effects of inaction on antimicrobial resistance, and how we can change the trajectory
-
Overcoming commercial and scientific challenges in the development of new antimicrobial agents
Like what you hear? Subscribe today: Apple Podcasts, Google podcasts, Stitcher, Spotify
Visit bmo.com/sustainabilityleaders-podcast for more information about the podcast
Related Resources
-
Why does antimicrobial resistance matter to pharmaceutical companies?
-
Why does antimicrobial resistance matter to food companies?
- Temps de lecture
- Écouter Arrêter
- Agrandir | Réduire le texte
Disponible en anglais seulement
November 18 marked the start of World Antimicrobial Awareness Week 2020, which aims to bring attention to the ever-evolving public health crisis of antimicrobial resistance (AMR) due to the overuse and misuse of antibiotics around the world.
Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, and James Anderson, Head of Corporate Government Affairs at GlaxoSmithKline, who leads the company’s advocacy on AMR, joins the podcast to discuss how antibiotic use in humans, livestock and plants is fueling AMR today. Plus, they provide an overview of engagement in this space to encourage responsible antibiotic use globally.
In this episode:
-
What is antimicrobial resistance and why is it such a pressing issue?
-
How the AMR Industry Alliance is combatting antibiotic overuse
-
Consumers and investors hold power to change antibiotic usage
-
The effects of inaction on antimicrobial resistance, and how we can change the trajectory
-
Overcoming commercial and scientific challenges in the development of new antimicrobial agents
Like what you hear? Subscribe today: Apple Podcasts, Google podcasts, Stitcher, Spotify
Visit bmo.com/sustainabilityleaders-podcast for more information about the podcast
Related Resources
-
Why does antimicrobial resistance matter to pharmaceutical companies?
-
Why does antimicrobial resistance matter to food companies?
Autre contenu intéressant
Boom, Bust and the Echo of History: Author John D. Turner in Conversation
BMO Equity Research on the AI + Data Center Build Out: Sustainability Impacts, Second Order Beneficiaries
Comment le secteur du capital-investissement s’adapte à l’évolution de la dynamique du marché
Budget fédéral de 2024 : Hausse de l’impôt sur les gains en capital; quelques pépites pour les entrepreneurs
Survol des sujets clés au congrès Mining Indaba, par le groupe BMO Equity Research
Le secteur du capital-investissement ouvert au risque, mais plus sélectif
Inflation, taux d’intérêt et économie : que nous réserve l’avenir?
Un marché des fusions et acquisitions actif, malgré le contexte macroéconomique
De formidables nouveaux facteurs donnent les moyens de croître aux activités de fusion et d’acquisition aux États-Unis